| |
| |
|
| Insider
Information: |
Andreotti Lamberto |
| Relationship: |
|
| City: |
Princeton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
1,011,868 |
|
|
Indirect Shares
|
241,273 |
|
|
| Direct
Value |
$43,876,119 |
|
|
|
Indirect Value
|
$10,642,552 |
|
|
| Total
Shares |
1,253,141 |
|
|
| Total
Value |
$54,518,671 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 14.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bristol-Myers Squibb Co |
BMY |
Director |
2017-04-07 |
935,571 |
2017-04-07 |
241,273 |
Premium* |
|
|
Mead Johnson Nutrition Co |
MJN |
Director |
2009-12-23 |
19,609 |
2009-02-17 |
0 |
Premium* |
|
|
DuPont de Nemours Inc |
DD |
Director |
2017-08-31 |
0 |
2012-08-02 |
0 |
Premium* |
|
|
Dowdupont Inc. |
DWDP |
Director |
2019-05-21 |
22,231 |
|
0 |
Premium* |
|
|
Corteva, Inc. |
CTVA |
|
2024-04-26 |
34,457 |
2019-06-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
218 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 9
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2012-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
9,083 |
314,725 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2012-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
5,240 |
317,815 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2012-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,349 |
312,575 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2012-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,344 |
317,263 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2012-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,453 |
319,495 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2012-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
109,780 |
425,513 |
0 |
- |
|
| DD |
DuPont de Nemours Inc |
Director |
– • – |
2012-08-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,210 |
2,210 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2013-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,344 |
409,335 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2013-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,453 |
412,524 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2013-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
26,872 |
766,483 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2013-03-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
330,160 |
739,611 |
0 |
- |
|
| DD |
DuPont de Nemours Inc |
Director |
– • – |
2013-04-24 |
4 |
A |
$0.00 |
$0 |
D/D |
2,470 |
4,740 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2013-05-04 |
4 |
A |
$0.00 |
$0 |
D/D |
8,859 |
591,316 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2013-05-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,989 |
582,457 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2014-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
49,880 |
586,517 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2014-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
423,533 |
912,318 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2014-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,240 |
738,383 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2014-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
19,854 |
758,237 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2014-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
27,613 |
658,396 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2014-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
12,534 |
670,930 |
0 |
- |
|
| DD |
DuPont de Nemours Inc |
Director |
– • – |
2014-04-23 |
4 |
A |
$0.00 |
$0 |
D/D |
1,940 |
6,826 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2014-05-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,990 |
662,469 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2014-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
13,990 |
676,459 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2015-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
231,280 |
643,964 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2015-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
33,531 |
416,594 |
0 |
- |
|
218 Records found
|
|
Page 2 of 9 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
